Search Results - Matteo Della Porta
- Showing 1 - 10 results of 10
-
1
-
2
-
3
-
4
Modification of metabolic syndrome parameters following the administration of polyglucosamine L112: results of a subgroup analysis of subjects enrolled in a double blind randomised... by Mariangela Rondanelli, Simone Perna, Matteo Della Porta, Federico Lombardoni, Zaira Patelli, Mara Nichetti, Clara Gasparri, Elvira Pistolesi, Benvenuto Cestaro, Roberta Cazzola
Published in BMC Nutrition (2025-09-01)Get full text
Article -
5
SARS-CoV-2 Interstitial Pneumonia Treated With Tocilizumab in a Patient Affected by Classical Hodgkin Lymphoma by Chiara Rusconi, Giulio Cassanello, Anna Guidetti, Chiara Oltolini, Vincenzo Marasco, Lucio Morabito, Matteo Della Porta, Rodolfo Lanocita, Gabriele Papagni, Cristiana Carniti, Paolo Corradini
Published in HemaSphere (2020-10-01)Get full text
Article -
6
Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes by Norbert Gattermann, Carlo Finelli, Matteo Della Porta, Pierre Fenaux, Michael Stadler, Agnes Guerci-Bresler, Mathias Schmid, Kerry Taylor, Dominique Vassilieff, Dany Habr, Andrea Marcellari, Bernard Roubert, Christian Rose
Published in Haematologica (2012-09-01)Get full text
Article -
7
Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin’s lymphoma patients: association with toxicity and survival by Donato Gemmati, Alessia Ongaro, Silvia Tognazzo, Linda Catozzi, Federica Federici, Endri Mauro, Matteo Della Porta, Diana Campioni, Antonella Bardi, Giuseppe Gilli, Agnese Pellati, Angelo Caruso, Gian L. Scapoli, Monica De Mattei
Published in Haematologica (2007-04-01)Get full text
Article -
8
Digital innovations in breast cancer care: exploring the potential and challenges of digital therapeutics and clinical decision support systems by Flavia Jacobs, Saverio D’Amico, Elena Zazzetti, Mariangela Gaudio, Chiara Benvenuti, Giuseppe Saltalamacchia, Riccardo Gerosa, Damiano Gentile, Angioletta Lasagna, Paolo Pedrazzoli, Corrado Tinterri, Armando Santoro, Rita De Sanctis, Matteo Della Porta, Alberto Zambelli
Published in Digital Health (2024-11-01)Get full text
Article -
9
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis by Sandra Parenti, Sebastiano Rontauroli, Chiara Carretta, Selene Mallia, Elena Genovese, Chiara Chiereghin, Clelia Peano, Lara Tavernari, Elisa Bianchi, Sebastian Fantini, Stefano Sartini, Oriana Romano, Silvio Bicciato, Enrico Tagliafico, Matteo Della Porta, Rossella Manfredini
Published in npj Precision Oncology (2021-02-01)Get full text
Article -
10
Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of ph... by Blanca Xicoy, Helena Pomares, Mireia Morgades, Ulrich Germing, Montserrat Arnan, Mar Tormo, Laura Palomo, Elisa Orna, Matteo Della Porta, Felicitas Schulz, Marina Díaz-Beya, Ada Esteban, Antonieta Molero, Luca Lanino, Alejandro Avendaño, Francisca Hernández, Verónica Roldan, Marta Ubezio, Alberto Pineda, María Díez-Campelo, Lurdes Zamora
Published in Frontiers in Oncology (2024-07-01)Get full text
Article
